Shuang Shang

6PUBLICATIONS
29CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Electrochemical energy storage and conversionCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 11, 2026
Glycocholic acid inhibits TRIB3-ID1 axis to acelerate colitis progression via suppressing intestinal stem cell renewal.

|Feb 09, 2026
Author Correction: ID1 expressing macrophages support cancer cell stemness and limit CD8+ T cell infiltration in colorectal cancer.

Shuang Shang, Chen Yang, Fei Chen

|Dec 13, 2023
Wild-type IDH1 maintains NSCLC stemness and chemoresistance through activation of the serine biosynthetic pathway.

Cheng Zhang, Jiao-Jiao Yu, Chen Yang

|Nov 23, 2023
ID1 expressing macrophages support cancer cell stemness and limit CD8+ T cell infiltration in colorectal cancer.

Shuang Shang, Chen Yang, Fei Chen

|Jan 05, 2022
TRIB3 reduces CD8+ T cell infiltration and induces immune evasion by repressing the STAT1-CXCL10 axis in colorectal cancer.

Shuang Shang, Yu-Wei Yang, Fei Chen

|Mar 25, 2021
Faciogenital Dysplasia 5 supports cancer stem cell traits in basal-like breast cancer by enhancing EGFR stability.

Ke Li, Ting-Ting Zhang, Chen-Xi Zhao

Pageof 1

Frequent Collaborators

6 joint publications

Fang Hua

4 joint publications

Xiao-Wei Zhang

4 joint publications

Jing Liu

3 joint publications

Xiao-Tong Liu